UBS Reaffirms Their Buy Rating on Danaher (DHR)

UBS analyst maintained a Buy rating on Danaher today and set a price target of $270.00.

Claim 50% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

In addition to UBS, Danaher also received a Buy from Barclays’s Luke Sergott in a report issued today. However, on the same day, TipRanks – OpenAI downgraded Danaher (NYSE: DHR) to a Hold.

Based on Danaher’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $6.84 billion and a net profit of $1.2 billion. In comparison, last year the company earned a revenue of $6.54 billion and had a net profit of $1.09 billion

Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DHR in relation to earlier this year. Most recently, in November 2025, Mitchell Rales, the Chairman of Exec. Committee of DHR sold 40,625.00 shares for a total of $9,359,066.67.